You are here

HEMODİYALİZDE E VİTAMİNİ VE E VİTAMİNİ İLE KAPLI DİYALİZ MEMBRANI KULLANIMI

THE USE OF VITAMIN E AND VITAMIN E COATED DIALYSIS MEMBRANE , DURING DIALYSIS TREATMENT

Journal Name:

Publication Year:

Keywords (Original Language):

Abstract (2. Language): 
In hemodialysis patients, oxidant stress increases and the antioxidant defence decreases. Reactive oxygen particles may increase tissue injury in the pathogenesis of human diseases. However, some antioxidants are used for therapeutic approach. In this review, the use of vitamin E and vitamin E-coated dialysis membrane will be discussed as an antioxidant treatment in hemodialysis patients.
Abstract (Original Language): 
Hemodiyaliz, hastalarında oksidan stres artmış ve antioksidan savunma azalmıştır. Reaktif oksijen partikülleri çoğu hastalıkların primer sebebi olmasalar da patogenezlerinde rol oynayabilir ve doku hasarını arttırabilirler. Bununla birlikte antioksidanlar kullanıma girmiştir. Bu makalede hemodiyaliz hastalarında antioksidan tedavi olarak E vitamini ve E vitamini ile kaplı diyaliz membranı kullanımı hakkında genel bir değerlendirme yapılacaktır
FULL TEXT (PDF): 

REFERENCES

References: 

Hasselwander O, Young IS. Oxidative stress in chronic renal failure. Free radical Res 1998; 29 : 1-11 Halliwell B. The role of oxygen radicals in human disease, with particular reference to the vascular
system. Haemostasis 1993; 23 ( Suppl 1): 118-126
Galle J. Oxidative stress in chronic renal failure. Neprol
Dial Transplant 2001; 16:2135-2137
Halliwell B. Antioxidant defence mechanisms : from
the beginning to the end. Free Radic Res 1999; 31 :
261-272
Galli F, Ronco C. Oxidative stress in hemodialysis.
Nephron 2000; 84 : 1-5
Comprehensive Clinical Nephrology, Section 14, Chapter 70. Editors: R. J. Johnson, J. Feehally, Mosby, 2000
Yeun J, Kaysen G. C-Reactive protein, oxidative stress, homocysteine and troponin as inflammatory and metabolic predictors of atherosclerosis in ESRD. Current Opinion in Nephrology and Hypertension
2000;9:621-630
Berry C, Brosnan M, Fennell, Hamilton C, Dominiczak A. Oxidative stress and vascular damage in hypertension. Current Opinion in Nephrology and
Hypertension 2001; 10 : 247-255
Galli F, Canestrari F, Buoncristiani U. Biological effects of oxidative stress in hemodialysis. Blood Purif
1999; 17:79-94
1.
3.
5.
6.
8.
9.
107
10. Ziouzencova O, Sevanian A, Abuja PM, Ramos P, Esterbauer H. Copper can promote oxidation of LDL by markedly different mechanisms. Free Radiol Biol Med 1998; 24: 607-623
11. Gesualdo L, Pertosa G, Grandaliano G, Schena FP. Cytokine and biocompatibility. Nephrol Dial
Transplant 1998; 13 : 1622-1626
12. Saccini c, Jialal I . LDL modification by activated PMNL: A cellular model of mild oxidative stress. Free
Radiol Biol Med 1994; 16 : 49-55
13. Trznadel K, Luciak M, Paradowski M, Kubasiewicz-Ujma B. Hemodialysis and the acute phase response in chronic uremic patients. Int J Artif Organs 1989; 12 : 762-765
14. Tetta C, Biasioli S, Schiavon R, Inguaggiato P, David S, Panichi V, Wratten Ml. Anoverview of hemodialysis
and oxidative stres. Blood Purif 1999; 17 : 118-126
15.
Çavda
r C, Sifil A, Çamsan T. Hastalıkları patogenez ve tedavisinde reaktif oksijen partikülleri ve antioksidanlar. Türk Nefroloji Diyaliz ve Transplantasyon Dergisi 1997; 3-4 : 96-101
16. Champe P, Harvey R. Lippincott's Illustrated Reviews :
Biochemistry, 2nd Edition, 1994; 340
17. Stephens NG, Parsons A, Schofield PM, et al.
Randomised controlled trial of vitamin E in patients with coronary disease : Cambridge Heart Antioxidant
Study (CHAOS). Lancet 1996; 347 : 781-786
18. Kaul N, Deveraj S, etal. Failure to demonstrate a major anti-inflammatory effect with alpha-tocopherol supplementation in normal subjects. Am J Cardiol 2001; 87: 1320-1323
19. Boaz M, Smenata S, Weinstein T, et al. Secondary prevention with antioxidants of cardiovascular disese ( SPACE ) : randomised placebo — controlled trial.
Lancet 2000; 356 : 1213-1218
20. Giardini O, Taccone-Gallucci M, Lubrano R, et al. Effects of alpha-tocopherol administration on red blood cell membrane lipid peroxidation in hemodialysis
patients. Clin Nephrol 1984; 21 : 174-177
21. Ono Keiji. Effects of large dose vitmin E supplementation on anemia in hemodialysis patients.
Nephron 1985;40:440-445
22. Taccone-Gallucci M, Giardini O, Ausiello C, et al. Vitamin E supplementation in hemodialysis patients : effects on peripheral blood mononuclear cells lipid peroxidation and immune response. Clin Nephrol 1986; 25:81-86
23. Taccone-Gallucci M, Lurano R, Del Principe D, et al. Platelet lipid peroxidation in haemodialysis patients . Effects of vitamin E supplementation. Nephrol Dial
Transplant 1989; 4 : 975-978
24. Yukawa S, Hibino A, Maeda T, et al. Effect of alpha-tocopherol on in vitro and in vivo metabolism of low-density lipoproteins in haemodialysis patients. Nephrol
Dial Transplant 1995; 10 (Suppl. 3) : 1-3
25. Cristol J P, Bosc J Y, Badiou S, et al. Erythropoietin and oxidative stress in haemodialysis : beneficial effects of vitamin E supplementation. Nephrol Dial
Transplant 1997; 12 : 2312-2317
26. Khajehdehi P, Mojerlou M, Behzadi S, et al. A randomized, double-blind, placebo-controlled trial of supplementary vitamins E, C and their combination for treatment of haemodialysis cramps. Nephrol Dial Transplant 2001; 16: 1448-1451
27. Roob JM, Khoschsorur G, Tiran A, Horina JH, Holzer H, Winklhofer-Roob B: Vitamin E attenuates oxidative stress induced by intrvenous iron in patients on
hemodialysis. J Am Soc Nephrol 2000; 11 : 539-549
28. Maccarrone M, Meloni C, Manca-di-Villahermosa, et al. Vitamin E suppresses 5-Lipoxygenase-Mediated Oxidative Stress in Peripheral Blood Mononuclear Cells of Hemodialysis Patients Regardless of Administration Route. American Journal of Kidney
Diseases 2001; 37: 964-969
29. Sasaki M, Hosoya N, Saruhashi M. Vitamin E Modified Cellulose Membrane. Artificial Organs 2000;
24(10):779-789
30. Buoncristiani U, Galli F, Rovidati S, et al. Oxidative damage during hemodialysis using a vitamin-E-modified dialysis membrane : A preliminary characterization. Nephron 1997; 77 : 57-61
31. Girndt M, Lengler S, Kaul H, et al. Prospective crossover trial of the influence of vitamin E-coated dialyzer membranes on T-cell activation and cytokine induction. American Journal of Kidney Diseases 2000; 35 : 95-104
32. Bonnefont-Rousselot D, Lehmann E, Jaudon M, et al. Blood oxidative stress and lipoprotein oxidizability in haemodialysis patients : effect of the use of a vitamin E-coated dialysis membrane. Nephrol Dial Transplant
2000; 15 :2020-2028
33. Omata M, Higuchi C, Demura R, et al. Reduction of neutrophil activation by vitamin E modified dialyzer
membranes. Nephron 2000; 85 : 221-231
34. Tarng D C, Huang T P, et al. Effect of vitamin e-bonded membrane on the 8-hydroxy 2'-deoxyguanosine level in lekocyte DNA of hemodialysis
patients 2000; 58 : 790-799
35. Satoh M, Yamasaki Y, et al. Oxidative stress is reduced by the long term use of vitamin E-coated dialysis
filters. Kidney International 2001; 59 : 1943-1950
36. Mune M, Yukawa S, et al. Effect of vitamin E on lipid metabolism and atherosclerosis in ESRD patients.
Kidney International 1999; 56 (suppl 71) : 126-129
37. Miyazaki H, Matsuaka H, et al. Hemodialysis impairs endothelial function via oxidative stress. Circulation
2000; 101 : 1002-1006
38. Mydlik M, Derzsiova K, Oliver Racz, et al. A modified diayzer with vitamin E and antioxidant defense parameters. Kidney International 2001; 59 (suppl 78) : 144-147

Thank you for copying data from http://www.arastirmax.com